Salud financiera de hoja de balance de YiChang HEC ChangJiang Pharmaceutical
Salud financiera controles de criterios 6/6
YiChang HEC ChangJiang Pharmaceutical tiene un patrimonio de accionistas total de CN¥8.7B y una deuda total de CN¥2.1B, lo que sitúa su ratio deuda-patrimonio en 23.9%. Sus activos y pasivos totales son CN¥12.5B y CN¥3.8B respectivamente. El BAIT de YiChang HEC ChangJiang Pharmaceutical es de CN¥2.1B, por lo que su ratio de cobertura de intereses es de 30.4. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥1.5B.
Información clave
23.9%
Ratio deuda-patrimonio
CN¥2.07b
Deuda
| Ratio de cobertura de intereses | 30.4x |
| Efectivo | CN¥1.52b |
| Patrimonio | CN¥8.67b |
| Total pasivo | CN¥3.83b |
| Activos totales | CN¥12.49b |
Actualizaciones recientes sobre salud financiera
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25
Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13Recent updates
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues
Oct 07Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?
Sep 19YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%
May 29Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?
Apr 23YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?
Oct 29Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially
Mar 23YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.
Mar 13YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?
Feb 20
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?
Feb 02YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 26Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend
Dec 13What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 30Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥5.5B) de 1558 superan a sus pasivos a corto plazo (CN¥2.5B).
Pasivo a largo plazo: Los activos a corto plazo de 1558 (CN¥5.5B) superan a sus pasivos a largo plazo (CN¥1.3B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (6.3%) de 1558 se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de 1558 ha pasado de 74.6% a 23.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de 1558 está bien cubierta por el flujo de caja operativo (21.9%).
Cobertura de intereses: Los pagos de intereses de la deuda de 1558 están bien cubiertos por el BAIT (30.4x cobertura).